Ligand validation:3MAX

NHE: 2-[N-CYCLOHEXYLAMINO]ETHANE SULFONIC ACID

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3MAX_NHE_A_383	61%	15%	0.142	0.929	1.93	1.86	1	4	0	0	100%	0.8385
4LXZ_NHE_B_404	57%	25%	0.139	0.915	0.95	2.07	1	5	2	0	100%	1
6WHQ_NHE_A_404	51%	20%	0.17	0.926	1.39	1.97	3	5	0	0	100%	0.839
6WHN_NHE_A_404	49%	16%	0.165	0.91	1.49	2.21	2	4	0	0	100%	0.8863
6WI3_NHE_A_404	45%	20%	0.192	0.924	1.37	1.99	3	5	0	0	100%	0.9
6WHO_NHE_A_404	42%	23%	0.166	0.884	1.32	1.83	3	5	0	0	100%	0.802
5TSP_NHE_A_1001	99%	51%	0.053	0.99	0.93	0.98	-	1	0	0	100%	1
3WXP_NHE_A_404	99%	10%	0.052	0.986	1.81	2.52	4	7	0	0	100%	0.94
2DSY_NHE_C_1001	99%	34%	0.051	0.979	1.49	1.14	1	1	0	0	100%	1
3WH6_NHE_A_505	99%	13%	0.056	0.984	1.25	2.71	2	5	0	0	100%	1
3O1W_NHE_B_488	98%	17%	0.063	0.985	1.36	2.21	1	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.